Navigating Sanctuary Sites in Non-Hodgkin Lymphoma Treatment

This chapter explores the challenges of treating aggressive non-Hodgkin lymphoma in immunoprivileged areas where standard therapies often lack efficacy. It emphasizes the potential of innovative therapies, particularly BTK inhibitors, in overcoming barriers like the blood-brain barrier to enhance treatment outcomes.